These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6127963)

  • 1. Does theophylline potentiate inhaled beta 2-agonists?
    Svedmyr K; Svedmyr N
    Allergy; 1982 Feb; 37(2):101-10. PubMed ID: 6127963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral theophylline combined with oral and inhaled beta-2-adrenostimulants in asthmatics.
    Svedmyr K
    Allergy; 1982 Feb; 37(2):119-27. PubMed ID: 6127964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation.
    Svedmyr K; Mellstrand T; Svedmyr N
    Allergy; 1982 Feb; 37(2):111-7. PubMed ID: 7137520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous treatment with terbutaline and theophylline.
    Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E
    Eur J Respir Dis Suppl; 1984; 134():211-8. PubMed ID: 6586482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels.
    Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E
    Eur J Respir Dis; 1982 Sep; 63(5):399-409. PubMed ID: 7140872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
    Löfdahl CG; Bengtsson B; Svedmyr K; Svedmyr N
    Allergy; 1982 Jul; 37(5):351-7. PubMed ID: 6127039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator intake and plasma levels on admission for severe acute asthma.
    Janson C; Boe J; Boman G; Mossberg B; Svedmyr N
    Eur Respir J; 1992 Jan; 5(1):80-5. PubMed ID: 1577155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo effects of theophylline and beta 2-adrenostimulants in combination.
    Svedmyr N; Svedmyr K
    Eur J Respir Dis Suppl; 1980; 109():83-91. PubMed ID: 6108228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prenalterol in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
    Scalabrin DM; Solé D; Naspitz CK
    J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of oral oxyphenonium bromide, terbutaline and theophylline against the bronchial obstructive effects of inhaled histamine, acetylcholine and propranolol.
    Koëter GH; Meurs H; Jonkman JH; Greving J; Leferink J; Sluiter HJ; de Zeeuw RA; de Vries K
    Eur J Clin Pharmacol; 1984; 26(4):435-41. PubMed ID: 6329769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
    Kaae R; Agertoft L; Pedersen S; Nordvall SL; Pedroletti C; Bengtsson T; Johannes-Hellberg I; Rosenborg J
    Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline in maintenance treatment of chronic asthma: concentration-dependent additional effect to beta 2-agonist therapy.
    Billing B; Dahlqvist R; Hörnblad Y; Leideman T; Skareke L; Ripe E
    Eur J Respir Dis; 1987 Jan; 70(1):35-43. PubMed ID: 2880747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients.
    Vandewalker ML; Kray KT; Weber RW; Nelson HS
    Chest; 1986 Aug; 90(2):198-203. PubMed ID: 3525022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
    Deenstra M; Haalboom JR; Struyvenberg A
    Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of the adverse effects of intravenous terbutaline by oral theophylline.
    Smith SR; Kendall MJ
    Br J Clin Pharmacol; 1986 Apr; 21(4):451-3. PubMed ID: 3707814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm.
    Shapiro GG; McPhillips JJ; Smith K; Furukawa CT; Pierson WE; Bierman CW
    Pediatrics; 1981 Apr; 67(4):508-13. PubMed ID: 7019839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new beta 2-adrenoceptor agonist--D 2343--with long duration. Inhalation comparison with terbutaline in asthmatics.
    Löfdahl CG; Svedmyr N
    Allergy; 1984 Aug; 39(6):485-9. PubMed ID: 6437263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.